1,502
Views
0
CrossRef citations to date
0
Altmetric
Original Article

A small molecule II-6s inhibits Enterococcus faecalis biofilms

, , , , , , & ORCID Icon show all
Article: 1978756 | Received 17 Jun 2021, Accepted 07 Sep 2021, Published online: 14 Sep 2021

Figures & data

Figure 1. (A) Chemical structure of II-6s. (B) Synthesis of compound II-6s. Reagents and conditions are as follows: (I) (R)-epichlorhydrin, AcOH, 75°C, 8 h; (II) KF, MeCN, reflux, 5 h; (III) 2-methyl-1-(naphthalen-2-yl)propan-2-amine hydrochloride, Et3N, EtOH, reflux, 7 h

Figure 1. (A) Chemical structure of II-6s. (B) Synthesis of compound II-6s. Reagents and conditions are as follows: (I) (R)-epichlorhydrin, AcOH, 75°C, 8 h; (II) KF, MeCN, reflux, 5 h; (III) 2-methyl-1-(naphthalen-2-yl)propan-2-amine hydrochloride, Et3N, EtOH, reflux, 7 h

Table 1. Primers used for quantitative real-time PCR

Table 2. MICs, MBCs, MBICs and MBRCs of test agents against E. faecalis strains

Figure 2. Kinetic killing effect of test agents on E. faecalis planktonic cultures. The concentrations of II-6s, NaOCl and CHX were at MBC values respectively. The untreated control was E. faecalis grown in BHI medium in the absence of II-6s, NaOCl or CHX. Data are means ± SD (n = 3)

Figure 2. Kinetic killing effect of test agents on E. faecalis planktonic cultures. The concentrations of II-6s, NaOCl and CHX were at MBC values respectively. The untreated control was E. faecalis grown in BHI medium in the absence of II-6s, NaOCl or CHX. Data are means ± SD (n = 3)

Figure 3. MIC values of test agents against E. faecalis. MICs were repeatedly measured from passage 0 (P0) to passage 10 (P10)

Figure 3. MIC values of test agents against E. faecalis. MICs were repeatedly measured from passage 0 (P0) to passage 10 (P10)

Table 3. Dilution coefficient of test agents

Figure 4. Cytotoxicity of test agents on macrophages 264.7, human periodontal ligament fibroblasts and human osteosarcoma MG63 cells. (A1-A3) Relative growth rate of RAW264.7, hPLFs and MG63 treated with II-6s; (B1-B3) Relative growth rate of RAW264.7, hPLFs and MG63 treated with CHX; (C1-C3) Relative growth rate of RAW264.7, hPLFs and MG63 treated with NaOCl. Data are means ± SD (n = 3). RAW264.7, macrophages RAW264.7; hPLFs, human periodontal ligament fibroblasts; MG63, human osteosarcoma MG63 cells

Figure 4. Cytotoxicity of test agents on macrophages 264.7, human periodontal ligament fibroblasts and human osteosarcoma MG63 cells. (A1-A3) Relative growth rate of RAW264.7, hPLFs and MG63 treated with II-6s; (B1-B3) Relative growth rate of RAW264.7, hPLFs and MG63 treated with CHX; (C1-C3) Relative growth rate of RAW264.7, hPLFs and MG63 treated with NaOCl. Data are means ± SD (n = 3). RAW264.7, macrophages RAW264.7; hPLFs, human periodontal ligament fibroblasts; MG63, human osteosarcoma MG63 cells

Figure 5. Effects of sub-MIC level of II-6s on the expression of virulence-associated genes in E. faecalis. Data are presented as means ±SD (n = 3). *, P< 0.05; ****, P< 0.0001 as compared to the untreated control group

Figure 5. Effects of sub-MIC level of II-6s on the expression of virulence-associated genes in E. faecalis. Data are presented as means ±SD (n = 3). *, P< 0.05; ****, P< 0.0001 as compared to the untreated control group

Figure 6. The antimicrobial effects of II-6s against 21-day-old E. faecalis biofilms in infected dentin tubules. (A) Representative image of dead/live bacteria within the dentinal tubules after treatment; live bacteria stained green; dead bacteria stained red; scale bar = 50 μm; (B) Proportion of dead bacteria after treatment; data are presented as mean ± SD (n = 5). Different lowercase letters indicate statistically significant differences between different treatment groups (P < 0.05)

Figure 6. The antimicrobial effects of II-6s against 21-day-old E. faecalis biofilms in infected dentin tubules. (A) Representative image of dead/live bacteria within the dentinal tubules after treatment; live bacteria stained green; dead bacteria stained red; scale bar = 50 μm; (B) Proportion of dead bacteria after treatment; data are presented as mean ± SD (n = 5). Different lowercase letters indicate statistically significant differences between different treatment groups (P < 0.05)
Supplemental material

Supplemental Material

Download MS Word (1.5 MB)